Cargando…
Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice
Seasonal influenza virus vaccines are effective when they are well matched to circulating strains. Because of antigenic drift/change in the immunodominant hemagglutinin (HA) head domain, annual vaccine reformulations are necessary to maintain a match with circulating strains. In addition, seasonal v...
Autores principales: | Puente-Massaguer, Eduard, Vasilev, Kirill, Beyer, Annika, Loganathan, Madhumathi, Francis, Benjamin, Scherm, Michael J., Arunkumar, Guha Asthagiri, González-Domínguez, Irene, Zhu, Xueyong, Wilson, Ian A., Coughlan, Lynda, Sun, Weina, Palese, Peter, Krammer, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499326/ https://www.ncbi.nlm.nih.gov/pubmed/37703367 http://dx.doi.org/10.1126/sciadv.adi4753 |
Ejemplares similares
-
Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses
por: Puente-Massaguer, Eduard, et al.
Publicado: (2023) -
Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface
por: Zhu, Xueyong, et al.
Publicado: (2022) -
Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
por: Asthagiri Arunkumar, Guha, et al.
Publicado: (2019) -
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
por: McMahon, Meagan, et al.
Publicado: (2019) -
Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma
por: Uslu, Ugur, et al.
Publicado: (2023)